SAA1 and nonpapillary renal cell carcinoma: Xu et al. demonstrated that SAA1 may serve as a novel marker for predicting the prognosis of ccRCC patients and may also be expressed in the tumor microenvironment (TME) through mast cell resting and PDL1 expression.